NCT06094569

Brief Summary

Patients with ischemic stroke in the posterior circulation continue to have high rates of mortality and disability, even with aggressive treatment. We wanted to evaluate preoperative imaging to screen patients with a good prognosis from mechanical embolization. We assess the degree of ischemia by defining the pons-midbrain-medulla index (PMMI) and correlate the preoperative PMMI with the clinical prognosis of postoperative patients to verify the validity of PMMI in predicting the clinical prognosis of patients with embolization.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,000

participants targeted

Target at P75+ for all trials

Timeline
45mo left

Started Jun 2019

Longer than P75 for all trials

Geographic Reach
1 country

4 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress66%
Jun 2019Dec 2029

Study Start

First participant enrolled

June 1, 2019

Completed
4.4 years until next milestone

First Submitted

Initial submission to the registry

October 16, 2023

Completed
7 days until next milestone

First Posted

Study publicly available on registry

October 23, 2023

Completed
6.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2029

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2029

Last Updated

October 23, 2023

Status Verified

October 1, 2023

Enrollment Period

10.6 years

First QC Date

October 16, 2023

Last Update Submit

October 16, 2023

Conditions

Keywords

select patientsendovascular thrombectomymagnetic resonance imagingdiffusion weighted imagingVertebrobasilar artery

Outcome Measures

Primary Outcomes (1)

  • Modified ranking scale (mRS) at 90 days

    A 0-6 scale running from perfect health without symptoms to death.

    90 days

Secondary Outcomes (1)

  • Mortality within 90 days

    90 days

Other Outcomes (3)

  • National Institutes of Health Stroke Scale (NIHSS) scores at 90 days

    90 days

  • Occurrence of periprocedural complications

    90 days

  • pc-ASPECT (posterior circulation Alberta Stroke Program Early CT score)

    0 days

Study Arms (2)

Endovascular therapy

Timely thrombectomy for acute ischemic stroke patients with large vessel occlusion by either stent retriever, thrombus aspiration, others, or combination methods.

Procedure: Endovascular Therapy

Best medical management

Patients enrolled in this group received the best medical management.

Interventions

Endovascular therapy, as an adjunct to standard stroke therapy, may be beneficial for a very select population of patients who present with an acute ischemic stroke and have a proven large, proximal occlusion on imaging. Endovascular therapy includes any one or more of the following: Intra-arterial thrombolytic therapy, aspiration, stent retrieval, or a combination of multiple mechanical devices

Endovascular therapy

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All acute ischemic strvoke patients with vertebrobasilar artery occlusion.

You may qualify if:

  • Patient admitted from Jun. 1st 2019 to Jan. 1st 2029;
  • Patients with acute ischemic stroke recently;
  • Symptoms persisted at admission, and MRI (including DWI) confirmed acute ischemic vertebrobasilar artery occlusion in the posterior circulation:(single right or left intracranial branch of vertebral artery occlusion ; single basilar occlusion ; both two vertebral arterys and basilar artery);

You may not qualify if:

  • Patiens can not meet the MRI examination conditions(with absolute and relative contraindications).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

Tianjin Medical University General Hospital

Tianjin, Tianjin Municipality, 300052, China

RECRUITING

The Sencond Hospital of Tianjin Medical University

Tianjin, Tianjin Municipality, 300211, China

RECRUITING

Tianjin Huanhu Hospital

Tianjin, Tianjin Municipality, 300222, China

RECRUITING

Beijing University Binhai Hospital

Tianjin, Tianjin Municipality, 300450, China

RECRUITING

Central Study Contacts

Ming Wei, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Chief Physician

Study Record Dates

First Submitted

October 16, 2023

First Posted

October 23, 2023

Study Start

June 1, 2019

Primary Completion (Estimated)

December 31, 2029

Study Completion (Estimated)

December 31, 2029

Last Updated

October 23, 2023

Record last verified: 2023-10

Locations